日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

SARS-CoV-2 Bottlenecks and Tissue-Specific Adaptation in the Central Nervous System

SARS-CoV-2 瓶颈和中枢神经系统中的组织特异性适应

Justin Richner, Jacob Class, Lacy Simons, Ramon Lorenzo-Redondo, Laura Cooper, Tanushree Dangi, Pablo Penaloza-MacMaster, Egon Ozer, Lijun Rong, Judd Hultquist

Improved control of SARS-CoV-2 by treatment with a nucleocapsid-specific monoclonal antibody

通过使用核衣壳特异性单克隆抗体治疗来改善对 SARS-CoV-2 的控制

Tanushree Dangi, Sarah Sanchez, Jacob Class, Michelle Richner, Lavanya Visvabharathy, Young Rock Chung, Kirsten Bentley, Richard J Stanton, Igor J Koralnik, Justin M Richner, Pablo Penaloza-MacMaster

The amino acid sensor GCN2 suppresses terminal oligopyrimidine (TOP) mRNA translation via La-related protein 1 (LARP1)

氨基酸传感器 GCN2 通过 La 相关蛋白 1 (LARP1) 抑制末端寡嘧啶 (TOP) mRNA 翻译

Zeenat Farooq, Fedho Kusuma, Phillip Burke, Catherine R Dufour, Duckgue Lee, Negar Tabatabaei, Phoenix Toboz, Ernest Radovani, Jack F Greenblatt, Jalees Rehman, Jacob Class, Arkady Khoutorsky, Bruno D Fonseca, Justin M Richner, Eloi Mercier, Guillaume Bourque, Vincent Giguère, Arvind R Subramaniam, 

Cross-protective immunity following coronavirus vaccination and coronavirus infection

冠状病毒疫苗接种和冠状病毒感染后的交叉保护性免疫

Tanushree Dangi ,Nicole Palacio ,Sarah Sanchez ,Mincheol Park ,Jacob Class ,Lavanya Visvabharathy ,Thomas Ciucci ,Igor J Koralnik ,Justin M Richner ,Pablo Penaloza-MacMaster

Combining spike- and nucleocapsid-based vaccines improves distal control of SARS-CoV-2

结合刺突蛋白和核衣壳蛋白疫苗可改善对SARS-CoV-2的远端控制

Tanushree Dangi ,Jacob Class ,Nicole Palacio ,Justin M Richner ,Pablo Penaloza MacMaster

mRNA induced expression of human angiotensin-converting enzyme 2 in mice for the study of the adaptive immune response to severe acute respiratory syndrome coronavirus 2

mRNA 诱导小鼠表达人类血管紧张素转换酶 2,用于研究对严重急性呼吸综合征冠状病毒 2 的适应性免疫反应

Mariah Hassert, Elizabeth Geerling, E Taylor Stone, Tara L Steffen, Madi S Feldman, Alexandria L Dickson, Jacob Class, Justin M Richner, James D Brien, Amelia K Pinto